Preclinical study demonstrates that sORF mutant strain EV76Δyp2 confers enhanced protection against plague with attenuated virulence in mice, highlighting its potential as a safer vaccine candidate.
We recently identified two virulence-associated small open reading frames (sORF) of Yersinia pestis , named yp1 and yp2 , and null mutants of each individual genes were highly attenuated in virulence. Plague vaccine strain EV76 is known for strong reactogenicity, making it not suitable for use in humans. To improve the immune safety of EV76, three mutant strains of EV76, Δ yp1 , Δ yp2 , and Δ yp1&yp2 were constructed and their virulence attenuation, immunogenicity, and protective efficacy in mice were evaluated. All mutant strains were attenuated by the subcutaneous ( s . c .) route and exhibited more rapid clearance in tissues than the parental strain EV76. Under iron overload conditions, only the mice infected with EV76Δ yp1 survived, accompanied by less draining lymph nodes damage than those infected by EV76. Analysis of cytokines secreted by splenocytes of immunized mice found that EV76Δ yp2 induced higher secretion of multiple cytokines including TNF-α, IL-2, and IL-12p70 than EV76. On day 42, EV76Δ yp2 or EV76Δ yp1&yp2 immunized mice exhibited similar protective efficacy as EV76 when exposed to Y . pestis 201, both via s . c . or intranasal ( i . n .) routes of administration. Moreover, when exposed to 200–400 LD 50 Y . pestis strain 201Δ caf1 (non-encapsulated Y . pestis ), EV76Δ yp2 or EV76Δ yp1&yp2 are able to afford about 50% protection to i . n . challenges, significantly better than the protection afforded by EV76. On 120 day, mice immunized with EV76Δ yp2 or EV76Δ yp1&yp2 cleared the i . n . challenge of Y . pestis 201- lux as quickly as those immunized with EV76, demonstrating 90–100% protection. Our results demonstrated that deletion of the yp2 gene is an effective strategy to attenuate virulence of Y . pestis EV76 while improving immunogenicity. Furthermore, EV76Δ yp2 is a promising candidate for conferring protection against the pneumonic and bubonic forms of plague.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: